Measles vaccination elicits a polyfunctional antibody response, which decays more rapidly in early vaccinated children.

Antibodies elicited in early-vaccinated children are equally polyfunctional to those elicited from children who received vaccination at 14 months. However, these antibody-functionalities decays more rapidly than those induced later in life, which may lead to suboptimal long-term protection.